ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.
about
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic ratsAngiotensin, inflammation, hypertension, and cardiovascular disease.Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kBRegulation of matrix proteins and impact on vascular structure.Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysmAngiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection.Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.Inflammation and atherosclerosis.Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.Single-pill combination of amlodipine and valsartan in the management of hypertension.Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts.Treatment of hypertension in metabolic syndrome subjects with amlodipine and olmesartan-effects on oxidized non-esterified free fatty acids and cytokine production.Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1.Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril.Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.
P2860
Q24800784-BDB533F6-8A2A-496C-A7DF-1F345158993AQ31935145-87908DBF-E6A5-4116-A5CC-2BD756E9F696Q33797156-EB5E5ED1-3656-413D-82F8-9747CF097F8DQ33888096-2E29A605-D5C7-4E02-BC17-EE61B14E6322Q34028447-5228976E-CC62-458A-9382-92F815CBE6F5Q34507683-E468FE7F-70C1-42E2-AD87-7C2DBC6B9257Q34634364-FE7E7404-9497-496F-922E-C762586B1A8DQ34706971-F1DB82E7-211A-41C8-96EA-3FA636347667Q35564174-DFB583FC-5773-4E0D-A7A8-1229BD819CAFQ35579754-8552C1A8-B16E-4756-ACBA-62B2B9A4DBFAQ35584790-F2E3C2DA-7E14-4E83-A011-BD7EE1074E48Q35692019-5656E575-8D4B-4DC0-8A3C-410CCF1E673EQ36985325-A29C0A24-EFD5-4A10-B446-A3FE84CF30E5Q37552939-D38B51E8-7456-49D3-9873-8632D4BA42A2Q40867324-97BD7D42-833F-4BD7-893F-9F147B3B6A66Q43903158-0A11A57E-ABD4-496E-825A-70433C206934Q43988479-52DF00FF-7B13-4309-91AB-3C16AB557867Q44600843-7AC6BE9C-494D-4C37-A20E-8A3727623CB2Q53479332-3D14B956-D5A2-4396-B430-2C815E00F078
P2860
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@en
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@nl
type
label
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@en
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@nl
prefLabel
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@en
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@nl
P2093
P2860
P1476
ACE inhibitor quinapril reduce ...... bbit model of atherosclerosis.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65697-0
P407
P577
1998-12-01T00:00:00Z